Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market: By Product: Disposables, Extracorporeal CO2 Machines, Others; By Access; By End Use; By Application; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments
Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Outlook
The global extracorporeal carbon dioxide removal (ECCO2R) devices market is expected to grow at a CAGR of 6.9% during the period 2022-2027. Significant technical advancements have improved extracorporeal techniques for carbon dioxide removal; such changes may help avoid worsening respiratory failure and respiratory acidosis, and possibly prevent or reduce the duration of IMV in patients with aggravation of COPD and asthma. North America, Europe and Asia are expected to be key markets.
Global Market Likely to be Driven by Need to Treat Conditions of Respiratory Failure
Respiratory failure is a condition often faced in the practice of critical care. In cases where there is an ineffective exchange of gases (such as in severe respiratory insufficiency), life-saving measures including mechanical ventilation are considered. While with significant benefit, positive-pressure ventilation has a risk of leading to complications like oxygen toxicity, lung-hyperinflation, and ventilator-associated pneumonia, among others. In such conditions that warrant gaseous exchange despite applicable MV settings, extracorporeal membrane oxygenation (ECMO) devices are employed. ECMO devices are available in different forms according to the circuit configured and the elements forming it.
Configurations that involve draining deoxygenated blood from the venous compartment and directing oxygenated-decarboxylated blood to a vein is called venovenous ECMO (VV-ECMO). When the blood is configured to return to the artery, it is veno-arterial ECMO (VA-ECMO). Extracorporeal carbon dioxide removal (ECCO2R) devices refer to specialized ECMO devices that primarily focus on CO2 removal, thereby decreasing PaCO2 and, in due course, the work of breathing and MV support. The potential advantage of extracorporeal carbon dioxide removal (ECCO2R) devices is decreased blood flow through the circuit. The membrane in action comprises polymethylpentene (PMP) or siloxane.
Arterio-venous extracorporeal carbon dioxide removal circuits do not require the pump in the configuration for functioning, while venovenous extracorporeal carbon dioxide removal requires pump.
Developments in the Domain Likely to Boost Market Growth
Over the last decade, extracorporeal support for respiratory failure has garnered much interest, in particular, extracorporeal carbon dioxide removal (ECCO2R), owing to relative ease and efficiency in blood CO2 clearance afforded by extracorporeal gas exchangers against oxygen delivery. Recent years have witnessed a new generation of extracorporeal carbon dioxide removal (ECCO2R) devices. Such developments are expected to drive the global extracorporeal carbon dioxide removal (ECCO2R) devices market. Increasingly efficient venovenous (VV)-ECCO2R devices have become available and replaced the arterio-venous approach, with the advantage of not needing arterial puncture. Modern VV-ECCO2R devices provide lower resistance to blood flow, possess smaller priming volumes, and offer a more efficient gas exchange with comparatively low extracorporeal blood flows (0.4–1 L/min).
Advanced Solutions by Leading Companies Likely to Stimulate Market Growth
Companies are engaged in providing modern solutions. For example, ApherCap is a simple multi-therapeutic platform that enables extracorporeal treatment for respiratory failure in acute critically ill patients, particularly: CO2 removal (ECCO2R); CO2 removal in combination with hemofiltration (ECCO2R + HF); and Emoperfusione (HP). In ECCO2R mode, ApherCap administers extra-corporeal CO2 removal therapies, decreasing the patient’s ventilatory needs with respiratory failure. Such solutions are likely to boost the global extracorporeal carbon dioxide removal (ECCO2R) devices market. The use of this method has been proposed in several clinical scenarios.
Extracorporeal carbon dioxide removal (ECCO2R) enables protracted treatments up to five days without replacement/modification of disposable kit; enables variable blood flow between 30 and 450 ml/min; and has a user-friendly interface.
Market Segmentation
By product, the market is classified into:
- Disposables
- Extracorporeal CO2 Machines
- Others
By access, the market is segmented into:
- Venovenous
- Arteriovenous
By end use, the market is classified into:
- Ambulatory Surgical Centres
- Hospitals
- Clinics
- Others
By application, the market is divided into:
- Chronic Obstructive Pulmonary Disease (COPD)
- Bridge to Lung Transplant
- Acute Respiratory Distress Syndrome (ARDS)
- Others
By region, the market is segmented into:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Key Industry Players in the Market
The report presents a detailed analysis of the following key players in the global extracorporeal carbon dioxide removal (ECCO2R) Devices market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Baxter International, Inc.
- Aferetica s.r.l.
- Getinge AB
- XENIOS AG
- Estor SpA
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2021 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Access |
|
| Breakup by End Use |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Analysis
8.1 Key Industry Highlights
8.2 Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Historical Market (2017-2021)
8.3 Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Forecast (2022-2027)
8.4 Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market by Product
8.4.1 Disposables
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Extracorporeal CO2 Machines
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Others
8.5 Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market by Access
8.5.1 Venovenous
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Arteriovenous
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.6 Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market by End Use
8.6.1 Ambulatory Surgical Centres
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Hospitals
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.6.3 Clinics
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2017-2021)
8.6.3.3 Forecast Trend (2022-2027)
8.6.4 Others
8.7 Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market by Application
8.7.1 Chronic Obstructive Pulmonary Disease (COPD)
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 Bridge to Lung Transplant
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.7.3 Acute Respiratory Distress Syndrome (ARDS)
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2017-2021)
8.7.3.3 Forecast Trend (2022-2027)
8.7.4 Others
8.8 Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Baxter International, Inc.
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Aferetica s.r.l.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Getinge AB
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 XENIOS AG
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Estor SpA
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market: Key Industry Highlights, 2017 and 2021
2. Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Historical Market: Breakup by Product (USD Million), 2017-2021
3. Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Forecast: Breakup by Product (USD Million), 2022-2027
4. Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Historical Market: Breakup by Access (USD Million), 2017-2021
5. Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Forecast: Breakup by Access (USD Million), 2022-2027
6. Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Historical Market: Breakup by End Use (USD Million), 2017-2021
7. Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Forecast: Breakup by End Use (USD Million), 2022-2027
8. Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Historical Market: Breakup by Application (USD Million), 2017-2021
9. Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Forecast: Breakup by Application (USD Million), 2022-2027
10. Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Historical Market: Breakup by Region (USD Million), 2017-2021
11. Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Forecast: Breakup by Region (USD Million), 2022-2027
12. North America Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Historical Market: Breakup by Country (USD Million), 2017-2021
13. North America Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
14. Europe Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Historical Market: Breakup by Country (USD Million), 2017-2021
15. Europe Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
16. Asia Pacific Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Historical Market: Breakup by Country (USD Million), 2017-2021
17. Asia Pacific Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
18. Latin America Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Historical Market: Breakup by Country (USD Million), 2017-2021
19. Latin America Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
20. Middle East and Africa Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Historical Market: Breakup by Country (USD Million), 2017-2021
21. Middle East and Africa Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Forecast: Breakup by Country (USD Million), 2022-2027
22. Global Extracorporeal Carbon Dioxide Removal (ECCO2R) Devices Market Structure
Key Questions Answered in the Report
The global extracorporeal carbon dioxide removal (ECCO2R) devices market is projected to grow at a CAGR of 6.9% between 2022 and 2027.
The major drivers of the market include the increasing number of regulatory product approvals during COVID-19, presence of a large patient pool, rising awareness regarding acute respiratory failure, increasing government healthcare expenditure, and rising preference for safe and rapid minimally invasive ventilation devices.
The growing need to treat conditions of respiratory failure and rise in incidence of acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD) are the key industry trends propelling the market's growth.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The various products in the market include disposables and extracorporeal CO2 machines, among others.
Based on access, the market is segmented into venovenous and arteriovenous.
The end-uses of the market include ambulatory surgical centres, hospitals, and clinics, among others.
The significant applications of the market include chronic obstructive pulmonary disease (COPD), bridge to lung transplant, and acute respiratory distress syndrome (ARDS), among others.
The major players in the industry include Baxter International, Inc., Aferetica s.r.l., Getinge AB, XENIOS AG, and Estor SpA, among others.
Analyst Review
The global extracorporeal carbon dioxide removal (ECCO2R) devices market has been driven by the growing need to treat conditions of respiratory failure in the historical period. Aided by the presence of a large patient pool and rising awareness regarding acute respiratory failure, the market is expected to grow at a CAGR of 6.9% in the forecast period of 2022-2027.
EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. The products in the market include disposables and extracorporeal CO2 machines, among others. Based on access, the market is segmented into venovenous and arteriovenous. The end-uses of the market include ambulatory surgical centres, hospitals, and clinics, among others. The significant applications of the market include chronic obstructive pulmonary disease (COPD), bridge to lung transplant, and acute respiratory distress syndrome (ARDS), among others. The major regional markets for extracorporeal carbon dioxide removal (ECCO2R) devices are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The major players in the market include Baxter International, Inc., Aferetica s.r.l., Getinge AB, XENIOS AG, and Estor SpA, among others.
EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global telehealth market attained a value of nearly USD 67.43 billion in 2021, driven by the increasing access to high-speed internet services and the emerging need to provide exceptional healthca...
The global healthcare revenue cycle management outsourcing market attained a value of nearly USD 20.4 billion, driven by the stringent regulations by the government. Aided by the rising medical instit...
The global epigenomics market was driven by the growing need to study complex diseases in the historical period. Aided by the rising prevalence of diseases such as cancer and increased funding for res...
The global external defibrillator market was driven by the increasing need to respond to cardiac arrest emergencies in the historical period. Aided by the rise in focus towards public access defibrill...
The global hunter syndrome treatment market attained a value of nearly USD 925 million in 2021, driven by technological advancements and the robust growth of the healthcare industry. Aided by the grow...
NEWSLETTER